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Abstract: 
Objective: The research purpose is to determine how much harmful use of benzodiazepine prevails among the 
medical students. 
Materials & Methods: We took 250 students, both gender medical students and studied them at Services Hospital, 
Lahore from January to September 2017. The students were in the age bracket of (18 – 25) years. Our excluding 
criteria were students having a history of chronic physical illness, and disorder of psychotic, mood, personality, and 
anxiety. We took informed consent from each student. Every student used and filled predesigned Pro-forma, which a 
single psychiatrist assessed for harmful use of benzodiazepine. 
Results: Among 250 students, 76.8% (192) were more than 21 years. Male and female students were 75.6% (189) 
and 24.4% (61) respectively (3.1:1 of the male-to-female ratio) with (22.5 ± 2.1) years of mean age. Only 7.6% (19) 
students used benzodiazepine harmful. 
Conclusion: We concluded that 7.6% harmful usage exists among medical students, which is a little higher 
percentage. 
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INTRODUCTION: 
BZOs widely prescription includes alprazolam, 
clonazepam, diazepam and lorazepam (Xanax, 
Valium, Klonopin, and Ativan respectively) and has 
its name among the top-100 most commonly 
prescribed medications [1]. BZO has an immediate 
effect generally and doctors prescribe it for short-
term needs. Due to increase and decrease in anxiety 
disorders from time to time, patients prefer using 
BZO because of its judicious use [2]. There are 
plenty of reasons like presurgical sedation, muscle 
spasticity, convulsive/involuntary movement 
disorders, alcohol detoxification, and 
cardiovascular/gastrointestinal related anxiety 
conditions for which doctors prescribe BZO [3]. APA 
report shows an (11% - 15%) of adults having used 
BZOs one in the preceding year while (1% - 2%) 
have used it daily for a year or more [2]. The use, 
dependence, and abuse of BZO in general population 
are less than in the substance-abuse population in 
psychiatric-treatment settings [4, 5]. As BZO has 
abuse potential with controlled substances, doctors 
should prescribe it after consulting patients’ addiction 
history. If a clinician understands the side-effects and 
toxicity of BZO, he may prescribe it with hypnotic 
and anxiolytic agents to reduce risks of medico-legal 
liability and improve treatment outcomes. As BZO 
has a rapid onset of action, addicts prefer it highly 
[6]. Chemical dependent patients highly reinforce 
such mood-changing medicines which are highly 
volatile (Vaporizable), potent, and soluble while 
using intravenously [7]. According to data, highly-
lipophilic BZOs which rapidly cross the blood-brain 
barrier (Like diazepam, alprazolam/lorazepam, which 
has high potency) shows the highest reinforcement 
that’s why to have a great chance of abuse [6]. Due to 
ease-of-access to drugs, work-stress, close contacts 
with death and illness, and sleep deprivation, health 
professionals and MSs show a high risk of harmful 
use of this substance. A study of MS shows a higher 
17% of illicit medicine harmful use which is 
unacceptable and threatening to their patient-care 
abilities [8]. Physicians training at medical college 
goes through a significant physiological distress 
which may produce an unintended mental and 
emotional negativity/instability [9]. As MS hold 
special place and responsibilities, that is why society 
expects highly professionalism out of them [10]. 
Therefore, the use of substance poses risks of losing 
effectiveness and practical-fitness as future doctors 
among MS. According to a belief, physicians start 
using substance early and it is very important to study 
the lifestyles of MS to study substance-abuse [10 – 
15]. Both genders uses BZO (especially during the 
exam) and is the only harmful substance [16]. 
Another study shows a 6.0% prevalence of BZO 
harmful use among MS [9]. Globally, especially in 
Pakistan, BZO is notorious for its significant 
dependency and self-harm through the higher 
frequency of use [18]. Reasons like peer pressure, 
experimentation curiosity, academic stress, insomnia, 
and getting “high” lead 96%, 88%, 90%, 34%, and 
88% students respectively towards using these drugs 
[19]. A study of Nepal shows hostel life, high 
expectations of parents, and huge syllabus whereas a 
study in Pakistan shows family depression history 
(28.90%) to be the main reasons stress [9]. The 
research purpose was to determine the prevailing 
harmful use of BZO among MS due to its wide 
acceptance of being a benign-sleeping-pills as no 
such study exists in past. This will prevail awareness 
among policymakers to discourage such harmful 
activities among MS to prevent future troubles. 
 
Operational Definitions: 
1. Medical student: First to Final Professional MBBS 
students (undergraduate) 
2. Benzodiazepines: A tranquillizing drug of sedative 
and hypnotic action to control anxiety. 
3. Harmful use: Use of BZO without physician’s 
prescription within the last month (Once or more). 
 
MATERIAL AND METHODS: 
We took 250 students, both gender medical students 
and studied them at Services Hospital, Lahore from 
January to September 2017. The students were in the 
age bracket of (18 – 25) years. Our excluding criteria 
were students having a history of chronic physical 
illness, and disorder of psychotic, mood, personality, 
anxiety and students unwilling to participate. 
 
After the recommendation of Ethical Review 
Committee, we took informed consent from 250 MS. 
Every student used and filled predesigned proforma, 
which a single psychiatrist assessed for harmful use 
of benzodiazepine. The two-part proforma consisted 
of demographic variables (Gender, age, and MBBS 
class) and study variables (Family Income/month, 
Home/Hostel residence, urban/rural background, and 
BZO intake frequency). 
 
We used SPSS to analysed collected data. We used 
frequency and percentage to present qualitative data 
(Gender, BZO harmful use) however Mean ± SD to 
present quantitative data (age). We controlled effect 
modifiers (age, locality, gender, monthly income) 
through stratification. We used graphs and tables to 
present results and Chi-Square test to present groups 
statistical difference. P-value of ≤ 0.05 was 
significant. 
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RESULTS: 
Among 250 students of (18 – 25) years, 76.8% (192) 
were more than 21 years. Male and female students 
were 75.6% (189) and 24.4% (61) respectively (3.1:1 
of the male-to-female ratio) with (22.5 ± 2.1) years of 
mean age. Only 7.6% (19) students used 
benzodiazepine harmful. After stratification, the 
study did not find any significant difference in 
harmful use of BZO between age/gender groups.  
 
Table – I: Age, Gender, Monthly Income, Locality and Benzodiazepine Harmful Use Stratification 
 
Variables Number Percentage 
Age 
18 – 20 Years 58 23.2 
20 – 23 Years 94 37.6 
> 23 – 25 Years 98 39.2 
Gender 
Male 61 24.4 
Female 189 75.6 
Monthly 
Income 
1000 - 3000 51 20.4 
3000 - 5000 57 22.8 
5000 - 10,000 68 27.2 
Above 10,000 74 29.6 
Residence 
Urban 153 61.2 
Rural 97 38.8 
Benzodiazepine 
Harmful Use 
Yes 19 7.6 
No 231 92.4 
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Table – II: Benzodiazepine Harmful Use Stratification among Different Variables 
 
Stratification 
Yes  No  P-
Value Number Percentage Number Percentage 
Age 
18 – 20 Years 1 1.72 57 98.28 
0.142 > 20 – 23 Years 8 8.51 86 91.49 
> 23 – 25 Years 10 10.2 88 89.8 
Gender 
Male  16 8.47 173 91.53 
0.363 
Female  3 4.92 58 95.08 
Monthly 
Income 
1000 - 3000 2 3.92 49 96.08 
0.110 
> 3000 - 5000 2 3.51 55 96.49 
> 5000 - 10000 5 7.35 92.65 92.65 
> 10000 10 13.51 86.49 86.49 
Residence 
Rural  5 5.15 94.85 94.85 
0.268 
Urban  14 8.92 143 91.08 
 
 
 
 
DISCUSSION: 
BZOs (also Benzos) are drugs used as minor 
tranquillizers. Doctors prescribe them to resolve sleep 
deprivation and anxiety. BZOs have thirty different 
types, each generic name sells under several 
names/brands of different companies [19]. BZO 
reduces central nervous system and brain’s working 
speed. BZOs help in sleeping and reducing anxiety 
medically to put the body into rest. To avoid its 
dependency, doctors prescribe them for short time (4 
weeks maximum) [19, 20]. Its non-prescribed use is 
becoming a global concern. Due to lack of data, 
ineffective monitoring (of health-care professionals), 
and non-medical use, the actual scale of this issue is 
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unknown. Monitoring instruments and studies related 
to substance abuse cover alcohol, drugs (illegal), and 
tobacco. However, the most attention requiring thing 
is the use of prescribed drugs as non-medical in 
numerous ways [21, 22]. Medical associations and 
institutions, and researchers have raised concerns 
about psychoactive drug’s non-medical use by 
physicians and MS [23, 24]. As physician 
themselves, sometimes, are involved in substance 
misuse but on the other hand, they can detect 
substance misuse at an early stage among their 
patients and colleagues providing appropriate 
services [23, 24]. The research purpose of our study 
is to determine how much harmful use of BZO 
prevails. We found 7.60% (19) students with BZO 
harmful use. A study shows this prevalence to be 6% 
[9]. Another research shows that the majority of MS 
are willing to self-prescribe BZO for short duration 
[17]. Ireland and UK studies shows (14%-35.60%) 
and 90% of illicit substance use and alcohol use 
respectively which is way higher than our research’s 
and subcontinent’s studies’ findings [24 – 26]. The 
study of Magalhaes et al. did in 1991 shows 5% BZO 
harmful use among 1069 students of the university 
[27]. Mesquita et al. show in his study (1995) 11% of 
prevalence in the same institute [11]. Harmful use of 
BZO among female students was more protective 
even after taking non-prescribed drugs, alcohol, 
tobacco, age and year of study into adjustments [25]. 
However, Western studies find this gender-gap to be 
small and found a higher rate of women with harmful 
substance use [15]. Women with excessive use of 
alcohol also show clear evidence of psychological, 
physiological, and medical harm [28]. Various 
studies describe this arising problem among 
medical/correlated students. Doctors with substance 
use show not only personal health risks but also 
professional inefficiencies improper patients’ check-
up, negligent behaviour, and personal health 
problems. Physicians using addictive substances may 
receive patients with the same issue less seriously 
[25]. Reasons for the substance use among college 
students are many like reduction of social, academic 
stress, social needs, recreation, the pursuit of 
pleasure, curiosity, making friends, improving energy 
levels to increase study times/academic performance 
and increase concentration [29, 30]. Moreover, MS 
have easy access to psychiatric drugs [29]. Moore et 
al. in his studies identify precursors of drug abuse of 
medical school including excessive smoking and 
alcohol intake, less religious affiliation, alcohol 
intake in public, anger in response to stress and 
anxiety. The risks-factors for substance use include 
higher academic-ranking, idealism/perfectionism in 
behaviour, and success in predicting traits [32, 33]. 
Lastly, we conclude that BZO harmful use, which 
7.6% among MS, is a little bit higher. 
 
CONCLUSION: 
We concluded that 7.6% harmful usage exists among 
MS, which a little high percentage. So, we 
recommend awareness campaigns to discourage this 
practice among MS. 
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